BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million

NEXT STORY
World Point-of-Care Testing Industry Report 2019-2022 – Opportunities Presented by Physical Robotic Telepresence & Smart Virtual Assistant in Association with Mobile Devices
PREV STORY
Wave Life Sciences Expands Board of Directors with Three New Appointments
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The global blood screening market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4%

author_avatar
NASDAQ Market News

SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

author_avatar
NASDAQ Market News

electroCore, Inc. Announces Exclusive Distribution Agreement with RSK Medical Inc. in Canada

author_avatar
NASDAQ Market News